TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3 ; volume:21 ; number:1 ; day:20 ; month:1 ; year:2021 ; pages:1-14 ; date:12.2021
Cancer cell international ; 21, Heft 1 (20.1.2021), 1-14, 12.2021
- Urheber
-
Liu, Shihai
Qiu, Jing
He, Guifang
He, Weitai
Liu, Changchang
Cai, Duo
Pan, Huazheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-020-01724-8
- URN
-
urn:nbn:de:101:1-2021031120561182765587
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Shihai
- Qiu, Jing
- He, Guifang
- He, Weitai
- Liu, Changchang
- Cai, Duo
- Pan, Huazheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
Erratum for: Toosendanin Inhibits Hepatocellular Carcinoma Cells by Inducing Mitochondria-dependent Apoptosis
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Chitopentaose inhibits hepatocellular carcinoma by inducing mitochondrial mediated apoptosis and suppressing protective autophagy
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL and thymocyte apoptosis : not so deadly?
NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling
TRAIL-induced apoptosis : between tumor therapy and immunopathology
TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway
Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma
Lactoferrin targeting INTL1 receptor inhibits hepatocellular carcinoma progression via apoptosis and cell cycle signaling pathways
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
Erratum for: Toosendanin Inhibits Hepatocellular Carcinoma Cells by Inducing Mitochondria-dependent Apoptosis
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Chitopentaose inhibits hepatocellular carcinoma by inducing mitochondrial mediated apoptosis and suppressing protective autophagy
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL and thymocyte apoptosis : not so deadly?
NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling
TRAIL-induced apoptosis : between tumor therapy and immunopathology
TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway
Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma
Lactoferrin targeting INTL1 receptor inhibits hepatocellular carcinoma progression via apoptosis and cell cycle signaling pathways
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
Erratum for: Toosendanin Inhibits Hepatocellular Carcinoma Cells by Inducing Mitochondria-dependent Apoptosis
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
Chitopentaose inhibits hepatocellular carcinoma by inducing mitochondrial mediated apoptosis and suppressing protective autophagy
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
TRAIL and thymocyte apoptosis : not so deadly?
NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling
TRAIL-induced apoptosis : between tumor therapy and immunopathology
TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway
Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma